20.91
1.51%
-0.32
Exelixis Inc (EXEL) 最新ニュース
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by BNP Paribas Financial Markets - MarketBeat
MarketBeat
July 19th Options Now Available For Exelixis (EXEL) - Nasdaq
Nasdaq
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Victory Capital Management Inc. - Defense World
Defense World
BNP Paribas Financial Markets Has $10.80 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL) - Defense World
Defense World
Exelixis, Inc. (NASDAQ:EXEL) Stock Holdings Lifted by M&T Bank Corp - Defense World
Defense World
Coherus BioSciences (NASDAQ:CHRS) versus Exelixis (NASDAQ:EXEL) Critical Contrast - Defense World
Defense World
Exelixis (EXEL), Sairopa Obtains IND Clearance for ADU-1805 - Yahoo New Zealand News
Yahoo New Zealand News
Exelixis (NASDAQ:EXEL) Research Coverage Started at Stephens - Defense World
Defense World
Exelixis director Jack Wyszomierski sells shares worth over $230k - Investing.com Australia
Investing.com Australia
Exelixis director Jack Wyszomierski sells shares worth over $230k - Investing.com
Investing.com
Exelixis director Jack Wyszomierski sells shares worth over $230k - Investing.com UK
Investing.com UK
Exelixis (EXEL) Wins FDA Nod for Cabometyx + Opdivo in RCC - Yahoo Movies UK
Yahoo Movies UK
Exelixis' (EXEL) IND for Oncology Candidate Accepted by FDA - Yahoo News UK
Yahoo News UK
Exelixis director Jack Wyszomierski sells shares worth over $230k - Investing.com South Africa
Investing.com South Africa
Exelixis (NASDAQ:EXEL) Receives New Coverage from Analysts at Stephens - MarketBeat
MarketBeat
Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Oversold Conditions For Exelixis (EXEL) - Nasdaq
Nasdaq
Exelixis reports new USP1 inhibitors - BioWorld Online
BioWorld Online
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Defense World
Exelixis (EXEL) Q3 Earnings & Sales Top, Cabometyx Aids Growth - Yahoo Movies Canada
Yahoo Movies Canada
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
The Motley Fool
Swiss National Bank Decreases Stake in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
MarketBeat
Exelixis sues Cipla over Cabometyx generics (NASDAQ:EXEL) - Seeking Alpha
Seeking Alpha
Exelixis (EXEL) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Movies Canada
Yahoo Movies Canada
Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by Swiss National Bank - Defense World
Defense World
Exelixis Files Patent Complaint Against Cipla's Cancer Treatment - MarketWatch
MarketWatch
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By ... - Markets Insider
Markets Insider
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
Benzinga
Exelixis price target raised to $29 vs. $25 at Oppenheimer - MSN
MSN
Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by LSV Asset Management - MarketBeat
MarketBeat
Here's Why Exelixis (EXEL) is a Strong Value Stock - Yahoo News UK
Yahoo News UK
New York Life Investment Management LLC Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL) - Defense World
Defense World
Top Ranked Momentum Stocks to Buy for June 27th - Yahoo News UK
Yahoo News UK
Exelixis (EXEL) Reports Break-Even Earnings for Q1 - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Exelixis (EXEL) Reports Break-Even Earnings for Q1 - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May - Business Wire
Business Wire
GAMMA Investing LLC Takes Position in Exelixis, Inc. (NASDAQ:EXEL) - Defense World
Defense World
Exelixis (EXEL) Wins FDA Nod for Cabometyx + Opdivo in RCC - Yahoo Movies UK
Yahoo Movies UK
Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality - Simply Wall St
Simply Wall St
Exelixis (EXEL) International Revenue Performance Explored
Zacks Investment Research
Exelixis (EXEL) International Revenue Performance Explored - Yahoo Canada Finance
Yahoo Canada Finance
Exelixis (EXEL) Announces Results From Phase II HNSCC Study - Yahoo New Zealand News
Yahoo New Zealand News
Exelixis: With Patent Litigation Decision Due Soon. There Are Options (NASDAQ:EXEL) - Seeking Alpha
Seeking Alpha
Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance
Yahoo Finance
The Analyst Verdict: Exelixis In The Eyes Of 5 Experts
Benzinga
Exelixis (EXEL) Shares Cross Below 200 DMA - Nasdaq
Nasdaq
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks Investment Research
Earnings call: Exelixis maintains 2024 guidance on strong Q1 results - Investing.com
Investing.com
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short - Yahoo Finance
Yahoo Finance
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
The Motley Fool
大文字化:
|
ボリューム (24 時間):